Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/26/2012CA2837134A1 Compounds for the treatment of neuropsychiatric disorders
10/26/2012CA2833623A1 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
10/26/2012CA2833614A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012CA2833571A1 Method of drug delivery for pth, pthrp and related peptides
10/26/2012CA2833434A1 Growth hormone releasing factor (grf) analogs and uses thereof
10/26/2012CA2833427A1 Stable pharmaceutical liquid formulations of the fusion protein tnfr:fc
10/26/2012CA2833409A1 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
10/26/2012CA2833371A1 Modified acid alpha glucosidase with accelerated processing
10/26/2012CA2833335A1 A method of peptide hydrolysis, peptidase, the composition for use as a bacteriostatic and bactericidal agent, a kit and the uses of the active form of lytm from s. aureus or derivatives thereof
10/26/2012CA2833326A1 Suspension type topical formulations comprising cyclic depsipeptide
10/26/2012CA2833173A1 Beta-2 microglobulin-deficient cells
10/26/2012CA2832152A1 Anticancer fusion protein
10/26/2012CA2831164A1 Infant formula for use in the prevention of cardiovascular diseases
10/25/2012US20120271361 Functionalized Nanodiamond Reinforced Biopolymers
10/25/2012US20120271032 Preparation of a Therapeutic Composition
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270813 Process for Preparing Peptide Products for Promoting Cholecystokinin Secretion and Use of the Peptide Products
10/25/2012US20120270812 Compositions, methods, and kits for determining an alkyl transferase
10/25/2012US20120270811 Conformations of divergent peptides with mineral binding affinity
10/25/2012US20120270810 Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270808 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
10/25/2012US20120270807 Macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120270806 Designer Cyclic Peptides - HIV gp120 Antagonists and their Applications
10/25/2012US20120270805 Cyclosporin compositions
10/25/2012US20120270804 Methods for the treatment and prevention of ocular disorders
10/25/2012US20120270803 Mitotic Kinesin Inhibitors and Methods of Use Thereof
10/25/2012US20120270802 Binding molecules for the treatment of myeloid cell malignancies
10/25/2012US20120270801 Her3 binding polypeptides
10/25/2012US20120270800 Bifunctional stapled polypeptides and uses thereof
10/25/2012US20120270799 METHOD OF IDENTIFYING A CANDIDATE COMPOUND WHICH MAY INHIBIT a9-nAchR OVEREXPRESSION OR ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN NICOTINE-DERIVED-COMPOUND-INDUCED BREAST CANCER CELLS
10/25/2012US20120270798 Compositions and Methods for Preventing or Treating Cancer
10/25/2012US20120270797 Engineered proteins including mutant fibronectin domains
10/25/2012US20120270796 Suspension Type Topical Formulations Comprising Cyclic Depsipeptide
10/25/2012US20120270795 Compounds for the treatment of diseases related to protein misfolding
10/25/2012US20120270794 Polymorphisms associated with parkinson's disease
10/25/2012US20120270793 Methods of treating a patient receiving a cardiac stent implant
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270791 Methods and Compositions for Treating and Diagnosing Kidney Disease
10/25/2012US20120270790 Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with annexin a1 short peptide
10/25/2012US20120270789 Treatment of coagulopathy with hyperfibrinolysis
10/25/2012US20120270788 Method of Administering Porcine B-Domainless fVIII
10/25/2012US20120270787 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
10/25/2012US20120270786 Intestine and muscle recovery
10/25/2012US20120270785 Therapy and Prevention of Problem Drinking
10/25/2012US20120270784 Growth hormone releasing factor (grf) analogs and uses thereof
10/25/2012US20120270783 Rapid opioid detoxification
10/25/2012US20120270782 Formulation for hgh and rhigf-1 combination
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270780 Method and composition for modulating erythropoiesis
10/25/2012US20120270779 Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
10/25/2012US20120270778 Compositions and Methods for Non-Invasive Treatment of Chronic Complications of Diabetes
10/25/2012US20120270777 Lactoferrin and gut neuronal health in adults and/or elderly
10/25/2012US20120270775 Crystalline forms of a potent hcv inhibitor
10/25/2012US20120270774 Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection
10/25/2012US20120270773 Trim5alpha mutants and uses thereof
10/25/2012US20120270772 Lipopeptide compositions and related methods
10/25/2012US20120270771 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270769 Methods of using macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120270768 Tumor Activated Prodrugs
10/25/2012US20120270767 Tumor Activated Prodrugs
10/25/2012US20120270766 Early programming of brain function through soy protein feeding
10/25/2012US20120270266 Nucleic ac1d and amino ac1d sequences encoding high-level expressor factor viii polypeptides and methods of use
10/25/2012US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus
10/25/2012US20120270202 Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
10/25/2012US20120269911 Compositions and Method for Enhancing Insulin Activity
10/25/2012US20120269908 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
10/25/2012US20120269895 Dendritic pic micelles with bioactive proteins
10/25/2012US20120269888 Barrier composition
10/25/2012US20120269883 MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/25/2012US20120269882 Brain Delivery of Insulin to Treat Systemic Inflammation
10/25/2012US20120269868 Compositions and methods for nutritional supplementation
10/25/2012US20120269863 Methods and compositions for regulating lymphocyte activity
10/25/2012US20120269862 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120269859 Multimer of extracellular domain of cell surface functional molecule
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269835 Process for the production of immunogenic compositions
10/25/2012US20120269830 Conjugates with improved pharmacokinetic properties
10/25/2012US20120269829 Inhibitors of Phosphatase and Tensin Homolog (PTEN) Compositions, Uses and Methods
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269808 Methods and compositions for modulating tweak and fn14 activity
10/25/2012US20120269806 Methods of inducing tolerance
10/25/2012US20120269804 Substituted benzosulphonamides
10/25/2012US20120269803 Substituted benzosulphonamides
10/25/2012US20120269802 Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression Profiling
10/25/2012US20120269798 Enhancement of regeneration by modulation of notum activity
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269796 Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes
10/25/2012US20120269795 Humanized recombinant uricase and mutants thereof
10/25/2012US20120269794 Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing
10/25/2012US20120269792 Eutectic-based self-nanoemulsified drug delivery system
10/25/2012US20120269788 Antidotes for factor xa inhibitors and methods of using the same
10/25/2012US20120269773 Recombinant adenoviruses encoding the specific iodine transporter (nis)
10/25/2012US20120269772 Lipid depot formulations
10/25/2012US20120269771 Sialochimeric compounds
10/25/2012US20120269770 Stable Preserved Compositions of Interferon-Beta
10/25/2012US20120269769 Hepatitis C Inhibitor Compounds
10/25/2012US20120269768 Antiviral product
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 3163